The mechanical interactions between virus-like particles and host cells may offer targets for new viral treatments and vaccines with modes of action t…

Our findings indicate partial direct protection by PCV13 against Spn3 colonisation acquisition, with differential protection against the clades and no protection by PPV23 against clade Iα. By contrast...

Vaccine safety is regarded as the absence of any serious adverse event following immunisation (sAEFI) in the vaccinated individual. The live oral poliovirus vaccine (OPV) causes an sAEFI—vaccine-assoc...

TITLE: Impact of needle-free delivery technologies on the vaccine-induced immune responses in pigs Speaker: Inés Có Rives, University College Cork, Ireland   TITLE: Development of an oral immunizat...

2026 ISV ANNUAL CONGRESS PROGRAM          ABSTRACT SUBMISSION          REGISTRATION

TITLE: HIV Vaccines Beyond Neutralizing Antibodies  PRESENTER: Shan Lu, UMASS Chan Medical School and Worcester HIV Vaccine (WHV) Time: US & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (GMT) | 17:0...

TITLE: Next-Generation Newborn Vaccines for Tuberculosis Prevention PRESENTER: Isaac Sakala, Australian National University     TITLE: Immunopeptidomics-based design of mRNA vaccine formulations...

Add to Calendar: here 09:00 – 09:15  Introduction: Nnenna Chime, MD, MPH, PhD, Sanofi 09:15 – 09:45  (EDT) Overview of HMPV vaccine development landscape Nnenna Chime MD, MPH, PhD, Sanofi   ...

PRESENTERS 09:00 – 09:30 (EDT) Development of universal flu vaccines - induction of cross reactive T cells Guus Rimmelzwaan , M.D., Ph.D Professor, TIHO Hannover   09:30 – 10:00 (EDT) Leveragin...

Title: What could possibly go wrong? Lessons learned the hard way from not thinking about IP early Speaker: Dr. Belinda Hartmann, Uniquest Pty Ltd     Title: Developing vaccines using the mole...

Title: What could possibly go wrong? Lessons learned the hard way from not thinking about IP early Speaker: Dr. Belinda Hartmann, Uniquest Pty Ltd     Title: Developing vaccines using the mole...

Title:Speeding up vaccine design and antibody discovery using cryoEM and AI/ML Speaker: Andrew Ward, Scripps Research, United States     MODERATOR:  Camila Coelho, Icahn School of Medicine at Mou...

Title: TBC Speaker: Andrew Ward, Scripps Research, United States     Time Zones: America & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST) Central & South America: 09:00 (Mexic...

2025 ISV's Annual Congress Visit Congress Website Congress Oral Programme View Congress Programme Early Bird Registration Late Breaker Abstracts Dear Delegates,

Title: Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform Speaker: Don Diamond, City of Hope, United States     Time Zones: America & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST) Central

Title: Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use. Speaker: Mateusz Hasso-Agopsowicz, World Health Organization, Switzerland   Time Zones: Americ...

Speakers & Presentation Title: TITLE: Why HIV Vaccines Are Still Needed SPEAKER: Glenda Gray, South African Medical Research Council       TITLE: Clinical Progress Toward Vaccine Induction o...

Speakers & Presentation Title: TITLE: Why HIV Vaccines Are Still Needed SPEAKER: Glenda Gray, South African Medical Research Council       TITLE: Clinical Progress Toward Vaccine Induction o...

Title: Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use Speaker: Agopsowicz, World Health Organization, Switzerland Time: 11:00-12:00 EST

SPEAKER Computational Modelling of Vaccine Responses Tal Einav, LaJolla Institute of Immunology, United States       Time: US & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (BST) | 17:00 (CEST)...

Zoom is the leader in modern enterprise cloud communications.